Figure1 (Letrozole Fig1)
Letrozole Tablet, Film Coated
Product Images NDC 59651-180
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 59651-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Letrozole Fig2)
This is a graph showing Kaplan-Meier estimates of time to progression for two medications, letrozole 2.5 mg and tamoxifen 20 mg. The graph is divided into months, but there is no further information or context provided.*
Figure 3 (Letrozole Fig3)
Figure4 (Letrozole Fig4)
The text describes a figure, labeled as "Figure 4", which depicts Kaplan-Meier estimates of time to progression in a study involving megestrol acetate. The x-axis is labeled "TIME TO PROGRESSION (IN DAYS)" and the y-axis is not specified. The treatment groups are represented by lines with different markers, including Letrozole 0.5 mg and Letrozole 2.5 mg. The figure shows the progression over time, with the Letrozole 2.5 mg treatment having a slower progression rate than the Letrozole 0.5 mg treatment.*
Figure5 (Letrozole Fig5)
The image shows a Kaplan-Meier plot with Time to Progression (in days) on the x-axis and treatment groups on the y-axis. The two treatment groups are Letrozole 0.5 mg and Letrozole 2.5 mg, and there is a third group labeled as "AG," which cannot be determined from the text. The plot shows the estimated probability of progression-free survival over time for each group.*
Package Label.principal Display Panel (2.5 mg Container Label (30 Tablets))
The text is a description of a medication called "Letrozole USP 2.5 mg" that comes in film-coated tablets. It is distributed by Aurobindo Pharma USA, Inc. and is made in India. The recommended storage temperature is between 20°C - 25°C (68°F - 77°F). The usual dosage information is available in the package insert. The text also mentions to keep the medication and all drugs out of the reach of children. The remaining text appears to be printing instructions and coding areas and is not relevant to the medication description.*
Structure (Letrozole Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
